Benitec Biopharma Inc. (BNTC)
NASDAQ: BNTC · Real-Time Price · USD
13.43
-0.30 (-2.15%)
At close: Mar 28, 2025, 4:00 PM
13.62
+0.19 (1.43%)
After-hours: Mar 28, 2025, 7:59 PM EDT
Benitec Biopharma Stock Forecast
Stock Price Forecast
The 7 analysts with 12-month price forecasts for Benitec Biopharma stock have an average target of 24.43, with a low estimate of 13 and a high estimate of 35. The average target predicts an increase of 81.91% from the current stock price of 13.43.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Benitec Biopharma stock from 7 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
---|---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 1 | 2 | 2 |
Buy | 4 | 4 | 5 | 5 | 5 | 5 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 5 | 5 | 6 | 6 | 7 | 7 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $28 | Strong Buy | Reiterates | $28 | +108.49% | Mar 24, 2025 |
Citizens Capital Markets | Citizens Capital Markets | Buy Reiterates $18 | Buy | Reiterates | $18 | +34.03% | Mar 18, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $28 | Strong Buy | Reiterates | $28 | +108.49% | Feb 21, 2025 |
Baird | Baird | Buy Initiates $30 | Buy | Initiates | $30 | +123.38% | Dec 13, 2024 |
Guggenheim | Guggenheim | Strong Buy Reiterates $17 | Strong Buy | Reiterates | $17 | +26.58% | Dec 3, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-1.43
from -5.51
EPS Next Year
-2.19
from -1.43
Revenue Forecast
Revenue | 2025 | 2026 | 2027 |
---|---|---|---|
High | n/a | n/a | n/a |
Avg | n/a | n/a | n/a |
Low | n/a | n/a | n/a |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 |
---|---|---|---|
High | - | - | - |
Avg | - | - | - |
Low | - | - | - |
EPS Forecast
EPS | 2025 | 2026 | 2027 |
---|---|---|---|
High | -1.10 | -1.33 | -1.58 |
Avg | -1.43 | -2.19 | -2.28 |
Low | -1.62 | -3.65 | -3.16 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 |
---|---|---|---|
High | - | - | - |
Avg | - | - | - |
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.